Epidemiologie Pharmacologie Investigation

Epidémiologie Pharmacologie Investigation (EPI) is a French contract research organization (CRO) specializing in pharmacoepidemiology and real-world evidence (RWE). Established in 1993 and headquartered in Le Bouscat, the company provides comprehensive support for Post-Authorization Safety Studies (PASS) and Post-Authorization Efficacy Studies (PAES). EPI leverages its deep expertise in analyzing large-scale healthcare databases, such as the French National Health Data System (SNDS), to provide insights into drug utilization and safety in real-world settings. Their multidisciplinary team offers services ranging from protocol design and data management to advanced statistical analysis and regulatory reporting. The company serves a global clientele of pharmaceutical and biotechnology firms, helping them navigate complex regulatory requirements from the EMA and other health authorities.